Devin Steenkamp

1.5k total citations
49 papers, 563 citations indexed

About

Devin Steenkamp is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Surgery. According to data from OpenAlex, Devin Steenkamp has authored 49 papers receiving a total of 563 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Endocrinology, Diabetes and Metabolism, 20 papers in Genetics and 18 papers in Surgery. Recurrent topics in Devin Steenkamp's work include Diabetes Management and Research (30 papers), Diabetes and associated disorders (20 papers) and Pancreatic function and diabetes (13 papers). Devin Steenkamp is often cited by papers focused on Diabetes Management and Research (30 papers), Diabetes and associated disorders (20 papers) and Pancreatic function and diabetes (13 papers). Devin Steenkamp collaborates with scholars based in United States. Devin Steenkamp's co-authors include Marie E. McDonnell, Mary M. Stevenson, Jagriti Upadhyay, Jeff M. Milunsky, Elliot Sternthal, Birong Liao, Hans Dooms, Barbara S. Nikolajczyk, Elizabeth L. Eby and Eleni Ritou and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Devin Steenkamp

46 papers receiving 548 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Devin Steenkamp United States 15 249 189 169 111 70 49 563
Bithika Thompson United States 12 290 1.2× 127 0.7× 124 0.7× 78 0.7× 106 1.5× 36 636
Selçuk Dağdelen Türkiye 14 431 1.7× 72 0.4× 134 0.8× 137 1.2× 23 0.3× 82 738
Selvihan Beysel Türkiye 13 129 0.5× 56 0.3× 91 0.5× 59 0.5× 97 1.4× 38 491
Sarah Nadeem Pakistan 9 255 1.0× 35 0.2× 177 1.0× 54 0.5× 94 1.3× 31 500
Emma Lindh Sweden 15 209 0.8× 143 0.8× 82 0.5× 148 1.3× 144 2.1× 31 787
Clemens Kamrath Germany 17 679 2.7× 501 2.7× 142 0.8× 344 3.1× 22 0.3× 70 1.0k
Ji Min Han South Korea 16 480 1.9× 74 0.4× 213 1.3× 81 0.7× 18 0.3× 37 666
Itxaso Rica Spain 16 353 1.4× 292 1.5× 273 1.6× 175 1.6× 12 0.2× 50 702
Mehmet Sargın Türkiye 11 200 0.8× 39 0.2× 53 0.3× 72 0.6× 23 0.3× 38 375
Lydie Pani United States 8 302 1.2× 108 0.6× 103 0.6× 207 1.9× 7 0.1× 12 651

Countries citing papers authored by Devin Steenkamp

Since Specialization
Citations

This map shows the geographic impact of Devin Steenkamp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Devin Steenkamp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Devin Steenkamp more than expected).

Fields of papers citing papers by Devin Steenkamp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Devin Steenkamp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Devin Steenkamp. The network helps show where Devin Steenkamp may publish in the future.

Co-authorship network of co-authors of Devin Steenkamp

This figure shows the co-authorship network connecting the top 25 collaborators of Devin Steenkamp. A scholar is included among the top collaborators of Devin Steenkamp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Devin Steenkamp. Devin Steenkamp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Martens, Thomas W., Holly Willis, Richard M. Bergenstal, et al.. (2025). A Randomized Controlled Trial Using Continuous Glucose Monitoring to Guide Food Choices and Diabetes Self-Care in People with Type 2 Diabetes not Taking Insulin. Diabetes Technology & Therapeutics. 27(4). 261–270. 2 indexed citations
3.
Levy, Carol J., Lauren Kanapka, Sue A. Brown, et al.. (2025). Simplified Meal Bolus Strategies with Control-IQ+ Automated Insulin Delivery Are Safe and Effective in Adults with Type 2 Diabetes. Diabetes Technology & Therapeutics.
4.
Lin, Honghuang, Devin Steenkamp, Joanne M. Murabito, et al.. (2025). Associations of diet composition and quality with continuous glucose monitor-derived glycemic metrics in a community-based cohort. American Journal of Clinical Nutrition. 122(4). 942–953. 1 indexed citations
5.
Spartano, Nicole L., Honghuang Lin, Huimin Cheng, et al.. (2024). Defining Continuous Glucose Monitor Time in Range in a Large, Community-Based Cohort Without Diabetes. The Journal of Clinical Endocrinology & Metabolism. 110(4). 1128–1134. 9 indexed citations
6.
Ferkowicz, Michael J., Ashish Verma, Daria Barwinska, et al.. (2023). Molecular Signatures of Glomerular Neovascularization in a Patient with Diabetic Kidney Disease. Clinical Journal of the American Society of Nephrology. 19(2). 266–275. 7 indexed citations
7.
Steenkamp, Devin, et al.. (2023). Optimizing Glycemic Outcomes for Minoritized and Medically Underserved Adults Living with Type 1 Diabetes. Endocrinology and Metabolism Clinics of North America. 53(1). 67–80. 1 indexed citations
8.
Steenkamp, Devin, et al.. (2023). Proof-of-concept Application of Continuous Glucose Monitoring Data Analytics to Identify Diabetes Glucotypes. Journal of the Endocrine Society. 7(5). bvad038–bvad038. 2 indexed citations
9.
Ebekozien, Osagie, Devin Steenkamp, J. Sonya Haw, et al.. (2022). Achieving Equity in Diabetes Research: Borrowing From the Field of Quality Improvement Using a Practical Framework and Improvement Tools. Diabetes Spectrum. 35(3). 304–312. 13 indexed citations
10.
Charoenngam, Nipith, et al.. (2022). Delays in Continuous Glucose Monitoring Device Initiation: A Single Center Experience and a Call to Change. Diabetes Technology & Therapeutics. 24(6). 390–395. 14 indexed citations
11.
Williams, Mark E., Devin Steenkamp, & Howard Wolpert. (2022). Making sense of glucose sensors in end-stage kidney disease: A review. SHILAP Revista de lepidopterología. 3. 1025328–1025328. 6 indexed citations
12.
Steenkamp, Devin, et al.. (2021). Advanced Diabetes Technology Remains Underutilized in Underserved Populations: Early Hybrid Closed-Loop System Experience at an Academic Safety Net Hospital. Diabetes Technology & Therapeutics. 24(2). 143–147. 13 indexed citations
14.
O’Malley, Grenye, Osagie Ebekozien, Marisa Desimone, et al.. (2020). COVID-19 Hospitalization in Adults with Type 1 Diabetes: Results from the T1D Exchange Multicenter Surveillance Study. The Journal of Clinical Endocrinology & Metabolism. 106(2). e936–e942. 37 indexed citations
15.
Cacicedo, José M., et al.. (2018). Comparison of proinsulin and C-peptide secretion in healthy versus long-standing type 1 diabetes mellitus cohorts: A pilot study. PLoS ONE. 13(11). e0207065–e0207065. 6 indexed citations
16.
Nicholas, Dequina, Elizabeth A. Proctor, Blanche C. Ip, et al.. (2017). Advances in the quantification of mitochondrial function in primary human immune cells through extracellular flux analysis. PLoS ONE. 12(2). e0170975–e0170975. 54 indexed citations
17.
Steenkamp, Devin, et al.. (2016). Fibrocalculous pancreatic diabetes.. PubMed. 41(1). 70–7. 1 indexed citations
18.
Steenkamp, Devin, et al.. (2014). Approach to the patient with atypical diabetes. Canadian Medical Association Journal. 186(9). 678–684. 15 indexed citations
19.
Steenkamp, Devin, et al.. (2014). Hypercalcemic Crisis: A Clinical Review. The American Journal of Medicine. 128(3). 239–245. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026